tiprankstipranks
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market

Silence Therapeutics (SLN) Cash flow

Compare
152 Followers

Silence Therapeutics Cash Flow

SLN's free cash flow for Q3 2024 was £-19.70M. For the 2024 fiscal year, SLN's free cash flow was decreased by £6.50M and operating cash flow was £-19.66M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
£ -39.35M£ -45.46M£ 6.81M£ -10.78M£ 1.73M
Investing Cash Flow
£ 16.43M£ -16.54M£ 8.68M£ 9.62M£ -15.02M
Financing Cash Flow
£ 25.16M£ 43.05M£ 30.71M£ 15.43M£ 5.27M
End Cash Position
£ 54.03M£ 54.82M£ 73.54M£ 27.45M£ 13.52M
Free Cash Flow
£ -39.40M£ -45.90M£ 5.47M£ -11.29M£ 1.72M
Currency in GBP

Silence Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis